Predicting response to peginterferon α‐2a, lamivudine and the two combined for HBeAg‐negative chronic hepatitis B

OBJECTIVE: In a trial of patients with hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B, 24 week post‐treatment biochemical and virological response rates with peginterferon α‐2a with or without lamivudine were significantly higher than with lamivudine alone. The effect of pre‐treatment fa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bonino, F, Marcellin, P, Lau, G K K, Hadziyannis, S, Jin, R, Piratvisuth, T, Germanidis, G, Yurdaydin, C, Diago, M, Gurel, S, Lai, M‐Y, Brunetto, M R, Farci, P, Popescu, M, McCloud, P
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Hepatitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1942152/
https://ncbi.nlm.nih.gov/pubmed/17127704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.089722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados